Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
about
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy.A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy.Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and Practices.Risk-Based Bioequivalence Recommendations for Antiepileptic Drugs.Advocacy for children with epilepsy: Leveraging the WHA resolution. Advocacy Task Force, Commission of Pediatrics, International League Against Epilepsy.
P2860
Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Switching generic antiepilepti ...... zures: A case-crossover study.
@en
Switching generic antiepilepti ...... zures: A case-crossover study.
@nl
type
label
Switching generic antiepilepti ...... zures: A case-crossover study.
@en
Switching generic antiepilepti ...... zures: A case-crossover study.
@nl
prefLabel
Switching generic antiepilepti ...... zures: A case-crossover study.
@en
Switching generic antiepilepti ...... zures: A case-crossover study.
@nl
P2093
P2860
P1433
P1476
Switching generic antiepilepti ...... izures: A case-crossover study
@en
P2093
Aaron S Kesselheim
Joshua J Gagne
Niteesh K Choudhry
Shirley V Wang
P2860
P304
P356
10.1212/WNL.0000000000003259
P407
P577
2016-09-28T00:00:00Z